Anastasia Budinskaya joined Gilde Healthcare in 2022 and focuses on Healthtech and Medtech investing. Before joining Gilde, Anastasia was a Scientific Leader in Neurology at GE Healthcare. She transitioned a new product into the GE Pharmaceutical Diagnostics portfolio from the start-up, LikeMinds, after being a part of the licensing transaction between the two companies. Prior to GE, Anastasia gained experience in corporate development, clinical development, and clinical trial administration at LikeMinds and Massachusetts General Hospital.
She holds an M.S. in Bioengineering Biomechanical Systems and Devices from Tufts University and a B.S. in Bioengineering from Syracuse University.